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Saudi Journal of Ophthalmology (2012) 26, 181–189Ophthalmic Pathology UpdateEndophthalmitis: A review of recent trendsJanice R. Safneck, MD, FRCPC ⇑AbstractEndophthalmitis is a feared complication of trauma, surgical procedures and septicemia. Although uncommon, its potential for
significant visual loss is well recognized. Especially over the past decade, complicated surgeries and medical techniques have
increased and seriously ill patients are being sustained in ever increasing numbers. New pathogens are being recognized and
known ones reclassified thanks to advances in molecular analysis. Continuously evolving PCR methodologies also add a new
dimension to the diagnosis of infectious endophthalmitis. As well, medical literature is now truly international, encompassing stud-
ies from around the world that expand our understanding of ocular infectious disease. This report reviews some of these changes
as they relate to endophthalmitis and particularly to the spectrum of organisms involved.
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http://dx.doi.org/10.1016/j.sjopt.2012.02.011IntroductionEndophthalmitis, defined as inflammation of one or more
coats of the eye and adjacent cavities, is an uncommon
potentially sight-threatening condition that varies geograph-
ically in incidence and in cause. It may be categorized by clin-
ical course (acute versus chronic), by etiology (infectious
versus non-infectious), by the route the causative agent en-
ters the globe (exogenous versus endogenous) and by the
organism(s) involved (bacteria, fungi, parasites and rarely,
viruses1). Certain organisms tend to be associated with par-
ticular clinical settings, means of intraocular access and types
of inflammation (acute, chronic non-granulomatous, chronic
granulomatous or mixed cellular response).
Studies looking at the overall incidence of endophthalmitis
yield differing results. For example, a recent British report
analyzing acute endophthalmitis trends between 1991 and
2004, found that of 120 cases, 59% were exogenous and
41% endogenous in origin.2 In comparison, another seriesPeer review under responsibility
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found 92.6% exogenous endophthalmitis and only 7.4%
endogenous endophthalmitis.3 Factors influencing variation
between multiple reported studies include the period in time
analyzed, prevalence of predisposing illnesses, geographic
factors in organism incidence, urban versus rural settings,
ethnicity, outpatient versus inpatient populations especially
those in tertiary care centers, and the small size of many
reported series.
Exogenous endophthalmitis
Exogenous endophthalmitis refers to infections resulting
from breach of the globe exterior through surgery or trauma,
or by fulminant progression of inflammatory processes such
as keratitis or scleritis.
Most postoperative endophthalmitis develops after cata-
ract surgery as millions of these procedures are performed
annually worldwide. Both acute endophthalmitis (generally
arising 24–48 h to a week post surgery) and chronic formsj Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
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Other procedures associated with varying risks of endoph-
thalmitis include corneal surgeries (penetrating keratoplasty,
keratoprosthesis insertion, refractive corneal surgeries), vitre-
ous procedures (intravitreal injections, vitrectomies), glau-
coma surgical treatments (blebs, glaucoma valve
placements), procedures to correct retinal detachment
including scleral buckling, and other miscellaneous ocular
surgeries, even strabismus correction. Most cases are spo-
radic but occasionally are clustered, suggesting contami-
nated materials/solutions or problems with instrument
sterilization likely are responsible.4,5 In these situations, unu-
sual bacterial pathogens may be found.
Several recent studies from different parts of the world
(India, China, Sweden, Norway, United Kingdom, USA) provide
post cataract surgery endophthalmitis incidence figures rang-
ing from 0.02% to 0.11% and post penetrating keratoplasty
endophthalmitis from 0.108% to 0.5%.6–12 Studies from the
Bascom Palmer Institute in Florida covering 3 separate time
periods (1984–1994, 1995–2001, 2002–2009) show a decrease
in post cataract surgery endophthalmitis from 0.08% to 0.05%
to 0.025% in the most recent series.10,11,13 The change was
attributed to progressive improvements in microsurgical and
aseptic techniques. The effect of utilizing clear corneal instead
of scleral incisions has raised fears of increased infection;
however, Lalwani et al.’s study14 also from Bascom Palmer,
found similar clinical and microbiologic data although the mean
time to presentation was increased.
Predominant symptoms include decreased vision and pain
while inability to visualize the fundus, pupillary fibrin membrane
and hypopyon are the most common findings.15 Generally
studies have found coagulase negative Staphylococcus is the
top pathogen,6–8,14 comprising in some series more than 60%
of isolates. Enterococci and streptococci were also frequent
in a study from Sweden6. However, in 2 reports from India,
the incidence of Gram positive and Gram negative bacteria
was approximately equal and more cases of Pseudomonas
aeruginosa endophthalmitis were identified.9,16 Although less
common than bacterial cases, fungal endophthalmitis can
occur post cataract surgery,17,18 and is more frequent in Indian
series where detection ofAspergillus sp. eclipsesCandida sp.18
The majority present acutely but latency periods of more
than 200 days have also been reported.18
In chronic endophthalmitis, a pale intracapsular plaque,
fibrinous reaction in the anterior chamber and uveitis may
be seen. Histopathological examination of explanted intraoc-
ular lens implants (IOLs) has revealed the presence of bacteria
in relation to lens capsule and/or on the IOL surface, accom-
panied by inflammatory cells including lymphocytes, plasma
cells and neutrophils.19 Less commonly, fungi (especially
Candida sp.) may be identified.20 Cultures, scanning and/or
transmission electron microscopy or DNA analysis21,22 have
found evidence of Staphylococcus sp. (especially S. epidermi-
dis), Propionibacterium acnes, filamentous bacteria (including
Actinomyces and Nocardia sp.) or mixed bacterial popula-
tion.19,21,23–25 The bacteria are usually a part of conjunctival
flora (although occasional reported organisms such as Entero-
coccus faecalis are not), and are capable of producing acute
endophthalmitis as well as chronic infections. They adhere
to IOLs and create microcolonies through biofilm formation
that consists of microbes, glycocalyx and surface. Glycocalyx
is a complex mixture of bacterial exopolysaccharides and
locally available cellular materials such as proteins and nucleicacids that together act as a glue.26 In biofilm, organisms are
well protected from host inflammatory responses, both
physically and through multiple genetic changes that alter
antigenicity. However, as the organisms multiply, those
that are shed outside the biofilm may revert to the original
form, rendering them vulnerable to attack. Organisms in the
biofilm are thus difficult to eradicate and may persist as a
nidus of infection despite apparent response to antibiotic
treatments, resulting in relapsing endophthalmitis.22Cornea-related endophthalmitis
The majority of endophthalmitis is bacterial27,28 and
mainly due to Streptococcus sp. and Staphylococcus sp. In
one series, Gram negative organisms caused approximately
a quarter of infections.27 Fungal (Candida sp.) endophthalmi-
tis also has been reported28–31 and may be increasing: cases
have been linked to donor-to-host spread and correlate with
longer donor cornea storage times.29 Recently, more limited
transplantation such as Descemet stripping automated endo-
thelial keratoplasty (DSAEK) is gaining favor. So far, there
have been limited reports of endophthalmitis post DSAEK,
with Mycobacterium abscessus,32 Streptococcus pneumo-
niae33 and Candida parapsilosis34 the pathogens involved.
In comparison, endophthalmitis secondary to keratitis is
predominantly bacterial, in both American and Indian
series.3,33,36 P. aeruginosa followed by Staphylococcus and
Streptococcus sp. are common causes with filamentous fungi
particularly Aspergillus sp.36 and Fusarium sp.37 making up to
40% of pathogens in one study.36 Contributing factors in-
clude dry eye, corneal perforation, systemic immune dysfunc-
tion and both topical and oral steroid use.35 Acanthamoeba
is well known for its ability to produce vision-threatening
keratitis that can be difficult to treat. However, it is highly
unusual for keratitis to progress to Acanthamoeba endoph-
thalmitis38,39 even though in Kitzmann et al.’s series40 this
occurred in 1 of 31 Acanthamoeba infected corneas.Endophthalmitis associated with vitreous procedures
Both infectious and non-infectious endophthalmitis have
been documented after intravitreal injections administering
triamcinolone or anti-vascular endothelial growth factor
agents (anti-VEGF). Risk is low but has increased as more
injections are performed. Endophthalmitis incidence varies
widely. Deriving meaningful conclusions from published data
requires careful assessment since most series are retrospec-
tive with non-uniform injection protocols of varying therapeu-
tic agents. Some large recently published/cited examples
include McCannel’s meta-analysis of 105,531 anti-VEGF
injections with 54 instances of endophthalmitis (0.049%), 26
of which were culture positive with Streptococcus sp. most
commonly isolated (31%)41; Jager’s meta-analysis of all kinds
of intravitreal injections with 24 cases of endophthalmitis per
14,866 injections, most frequently due to Staphylococcus
sp.42; and Murray’s series of 34, 278 injections with 9 cases
of endophthalmitis (0.03%), 5 of which were culture positive,
predominantly Streptococcus.43 A subset of this latter group
performed with standardized protocols, sterile techniques
and patient follow-up had just one case of endophthalmitis
(Staphylococcus epidermidis) in 10,142 injections.43 Other
organisms reported include Hemophilus influenzae and
Endophthalmitis: A review of recent trends 183Mycobacterium chelonae abscessus.44 Differentiation be-
tween infectious and non-infectious endophthalmitis is often
a challenge. Irigoyen et al.45 found commonly cited factors
for distinction, i.e., lack of pain, conjunctival injection and ear-
lier presentation, were not always helpful; in her study, they
applied reasonably well to infectious endophthalmitis post
anti-VEGF injection but were only rarely apparent in bacterial
endophthalmitis following triamcinolone injections. Her
group also noted 12 patients who had poor visual outcomes
although this may have been at least in part due to underly-
ing conditions. Since all endophthalmitis cases in the series
presented within the first 48 h, vigilance from 24 to 72 h post
injection was recommended.
Concerns have been raised that increasing use of suture-
less 25-gauge vitrectomy would lead to an increased inci-
dence of exogenous endophthalmitis over that found with
20-gauge pars plana vitrectomy. Study results have been
conflicting and a recent meta-analysis of 6 large series found
interinstitutional differences in surgical practices and the
population base made drawing conclusion difficult.46 How-
ever, diabetes mellitus is recognized as a risk factor for exog-
enous endophthalmitis in all types of vitrectomy.Glaucoma surgery endophthalmitis
Glaucoma related surgeries, blebs and implants (Molte-
no, Baerveldt and Ahmed), also may be associated with
infectious endophthalmitis (Fig. 1). A large study of Ahmed
glaucoma valves (542 eyes in 505 patients) from Riyadh
found endophthalmitis developed in 9 eyes (1.7%).47 Com-
bining these findings with a review of reports from 1991
to 2003 yielded 27 instances of endophthalmitis in 1427
cases with an occurrence rate of 1.9%. Endophthalmitis
developed 63–330 days post valve insertion. Both acuteFigure 1. Mycobacterial endophthalmitis post Ahmed valve insertion (A). A
hematoxylin and eosin, 40). Acid fast bacilli are noted in suppurative inflamand chronic forms occurred and children are much more
likely to be affected than adults. Conjunctival erosion
overlying the valve tube was common. Most frequent organ-
isms were Haemophilus influenzae and Streptococcus sp.
and less commonly, P. aeruginosa.47 Similarly, both acute
and delayed onset endophthalmitis may develop with filter-
ing blebs, reported to occur in 0.2–9.6% of cases. In a re-
cent series of 71 eyes from 68 patients, one quarter of
patients had a bleb leak and 83% were culture positive, pre-
dominantly for Streptococcus sp., a variety of Gram nega-
tive organisms (Moraxella sp., P. aeruginosa, H. influenzae,
Serratia sp.) and coagulase negative Staphylococcus. Thir-
teen percent (9 eyes) had polymicrobial infections and the
same percentage ultimately was eviscerated/enucleated.48
More virulent organisms than seen in post cataract surgery
endophthalmitis and poor visual outcomes have been noted
in other studies as well.48Exogenous endophthalmitis secondary to trauma
Posttraumatic endophthalmitis has an overall frequency of
<1–18.9% in recently reported series.49–54 Intraocular culture
results post-trauma do not necessarily correlate with the
presence of endophthalmitis.53 Onset may be acute or de-
layed but the most virulent organisms can destroy an eye in
hours. Risk factors for infection differ in various series and
comparison can be challenging as series are usually retro-
spective and treatment practices not consistent; outcomes
also vary widely with trauma and endophthalmitis related
damage together impairing successful recovery. Amongst
the best results reported were visual acuity of 20/200 or bet-
ter in 67% of patients55 Longer time between injury and
examination, poorer visual acuity at presentation, virulence
of organisms, and the presence of an intraocular foreignbundant inflammation was seen especially at the tube insertion site (B,
mation without giant cells or granulomas (C, ZN 600).
184 J.R. Safneckbody (IOFB) were often reported as significant for endoph-
thalmitis development.50,53,56,57
In both adult and pediatric series of posttraumatic
endophthalmitis from around the world, Staphylococcus
and Streptococcus sp. are the most frequent pathogens
55,58,59 P. aeruginosa and B. cereus also are frequently identi-
fied51,60 but their prevalence varies with geographic location.
Bacillus sp. infections are noteworthy for the rapid
destruction they can cause, with visual loss and often loss
of the eye in hours to a few days after injury (Fig. 2). In two
retrospective series, only 15 of 31 and 8 of 22 patients with
Bacillus sp. endophthalmitis ultimately had visual acuity bet-
ter than 20/400.61,63 Bacillus sp. have been reported as
responsible for 15–46% of post-traumatic endophthalmitis
but are only rarely isolated from post-surgical endophthalmi-
tis cases.62 B. cereus is most commonly found in America62
while in an Indian study,61 a variety of species were isolated
and some infections were caused by a mixture of Bacillus
sp. Bacillus organisms are spore-forming Gram positive rods,
ubiquitous in soil, water and dust. Initial reports suggested
that these bacteria were particularly associated with metal
object lacerations but a variety of trauma causes have been
reported. Virulence is attributable to bacterial toxins – hem-
olysins, lipases, enterotoxins and proteases – acting to-
gether.63 As well, wild-type motile strains are more virulent
than non-motile ones as they can cause not only posterior
disease but also anterior segment destruction.64 Experimen-
tal studies have demonstrated that decline in retinal function
and neutrophilic infiltration of vitreous can occur as fast as 4 h
post-infection,65 suggesting that therapeutic interventions
must be initiated rapidly if vision is to be saved.
In two recent studies from Saudi Arabia56 and India,66 fun-
gi made up 3.8% and 7.3% of post-traumatic endophthalmitis
respectively. Gupta et al noted filamentous fungi especially
Aspergillus sp. and Fusarium sp. were usually isolated.66
The incidence of endophthalmitis associated with IOFBs
varies but they generally increase the risk of endophthalmitis
over that associated with open globe injury alone. Bhagat
et al.57 in their extensive literature review of post-traumatic
endophthalmitis noted a range of 3.1–30% without an IOFBFigure 2. Bacillus sp. post-traumatic endophthalmitis (A) leading to eviscerati
were seen in the inflammatory debris (B, Gram stain, 1000).and 1.3–60% with an IOFB.57 Degree of risk is dependent
on size and composition of the foreign body including any
contaminating materials such as soil, the speed with which
it enters the globe, its path within the eye, the length of time
between injury and foreign body removal, and the immune
system of the affected individual in addition to treatment
undertaken. Most endophthalmitis associated with IOFBs is
bacterial, and Bacillus sp. are particularly of concern in this
setting. In addition, vision-threatening sterile reactive
endophthalmitis also can develop from IOFBs, in particular
with metallic IOFBs, especially copper.57Endogenous endophthalmitis
Endogenous or metastatic endophthalmitis is typically the
result of hematogenous spread. It is highly unusual for indi-
viduals with endogenous endophthalmitis to have no risk fac-
tors for systemic infection67 although it has been reported.68
Patients generally have a history of chronic illness (diabetes,
HIV, malignancy, intravenous drug use), transplantation,
immunosuppressive therapy, and/or catheterization. Bacteria
and fungi are the most common pathogens, the former typ-
ically Staphylococcus sp., Streptococcus sp. and Klebsiella
pneumoniae, the latter generally Candida sp. or Aspergillus
sp. A variety of organisms, including agents that are little
known and/or otherwise of limited virulence have been
increasingly found.69 Even protozoa such as Microsporidia70
and amoebae71 may be pathogens, including in patients with
no history of HIV infection. In culture proven endogenous
endophthalmitis, fungi typically exceed bacteria as iso-
lates,72–74 62% versus 38% as illustrated by one recent
study75 but in some but not all East Asian populations, bacte-
ria are more frequent.76
The vast majority of affected individuals are adults with
pediatric endogenous endophthalmitis representing be-
tween 0.1% and 4% of cases, incidence dependent on cohort
location with higher rates in India than in America.77 Patients
may have overt systemic sepsis, or the initiating focus of
infection may be occult, consisting of either multiorganon 48 h after penetrating injury with metallic shards. Numerous organisms
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pathogens, possibly with only transient bacteremia/fungemia
as an explanation for the infective endophthalmitis.78,79 Both
these scenarios can present diagnostic perils. Patients with-
out obvious systemic infection may have their endophthalmi-
tis misdiagnosed,75,80,81 or have it thought to be a strictly
ocular process, leaving unrecognized possibly devastating
disease elsewhere (for example, endocarditis). Seriously ill
patients may neglect or be unable to mention eye symptoms
and medical staff may be so focused on other pressing issues
that endophthalmitis is overlooked until vision is permanently
compromised.
Some literature reports suggest endogenous endophthal-
mitis is increasing, perhaps because of expanded transplan-
tation, more complicated surgeries and the ability to keep
serious ill patients alive longer. Consequently, it has been
recommended that ophthalmic screening should be routine
in high risk situations such as intravenous drug use, long term
antibiotics, immunosuppressive therapy, primary or second-
ary immunodeficiency, prolonged central line use, debilitated
patients and premature infants.82 On the other hand, even in
the setting of culture-proven sepsis, endogenous endoph-
thalmitis is unusual. Lingappan et al.83 found no cases of
endophthalmitis in the routine screening of patients with
fungemia. Feman et al.84 observed that of 82 patients with
systemic fungal disease, only 2 patients developed endoph-
thalmitis and Dozier et al.85 noted that of 211 patients with
positive fungal cultures at a tertiary care center, less than
1% had ocular involvement.
These apparently conflicting findings illustrate that endog-
enous endophthalmitis is a complex subject. In part, this re-
lates to the patient population studied, their risk factors, to
the organism(s) involved and to the early administration of
antibiotic/antifungal agents in bacteremic/fungemic patients.
Candida sp. are the most commonly reported causes of
endogenous endophthalmitis,67,86,87 perhaps not surprisingly
as yeasts including Candida make up 25% of blood stream
infection acquired in American hospitals.88 However, while
historically the rate of intraocular Candida sp. infections
was between 9% and 45%,67 current rates are around 1–2%
likely due to the early identification of Candida and prompt
administration of antifungal agents in septic patients.84,89
Two recent series are illustrative of this point. In a Scandina-Figure 3. Bilateral Aspergillus sp. endophthalmitis in a renal transplant patien
(A). Globe at autopsy with hazy vitreous and pale thickened retina (B). Micros
with fungal hyphae (C, hematoxylin and eosin, 200).vian study of 203 patients with Candidemia, 9 cases of retini-
tis and 1 of endophthalmitis were detected.88 In a similar
American study of 38 patients with Candidemia, 8 had chori-
oretinitis but none had endophthalmitis.90 In excess of 150
Candida species are documented human pathogens, yet
Candida albicans remains the most important although oth-
ers such as C. glabrata, C. tropicalis, C. dubliniensis and C.
krusei are being increasingly detected.91 C. albicans has been
shown in several reports to have a greater risk of progression
from chorioretinitis to endophthalmitis, in keeping with
greater virulence and prevalence,89,90 while the opposite is
true of C. parapsilosis.89 Risk factors for the development
of Candida endogenous fungal endophthalmitis include dia-
betes, antibiotic use, gastrointestinal surgery, catheters, solid
tumors, intravenous drug use and immunosuppres-
sion.78,79,87,92–94 Many patients with identified ocular disease
are without ocular symptoms89 or present in a subacute fash-
ion with altered vision, low-grade pain, photophobia and
injection.90 Experimental models of C. albicans endogenous
endophthalmitis have shown the initial lesions appear at the
equator then spread posteriorly, and animals with prior ste-
roid treatment had more fungal pseudohyphae than those
without.95 Histopathologic study of clinical enucleation spec-
imens have demonstrated Candida organisms in vitreous with
associated suppurative non-granulomatous inflammation and
typically minimal if any choroidal or retinal necrosis.93 These
findings are consistent with 76–85% of endogenous Candida
endophthalmitis patients having final visual acuities of 20/200
or better.78,96
In studies of endogenous fungal endophthalmitis, Asper-
gillus sp. have been reported less frequently than Candida
sp., 75% versus 25% in an American study83 but are much
more visually devastating.75,79,97,98 Aspergillus endogenous
endophthalmitis often presents with nonspecific symptoms
but rapidly progressive retinal damage soon occurs (Fig. 3).
Histopathological analysis of enucleated globes has shown
involvement of retinal and choroidal vasculature with retinal
necrosis and predominantly a neutrophilic inflammatory re-
sponse although chronic granulomatous inflammation may
be found.93,98 Septate fungi with 45 angle branching are
typical of Aspergillus sp. but do not permit definitive diagno-
sis as some other molds (e.g. Monosporium apiospermum/
Pseudoallescheria boydii) can be morphologically similar.t. Endocarditis was suspected but not confirmed until just prior to death
copy revealed abundant neutrophilic inflammation in vitreous and retina
186 J.R. SafneckCulture and/or PCR technique are needed for definitive diag-
nosis. Aspergillus fumigatus is the most common species
found with A. flavus second. However, in some studies, Fusar-
ium sp. outnumber Aspergillus sp.79
Risk factors for endogenous Aspergillus endophthalmitis
include corticosteroid use, intravenous drug use, solid organ
and stem cell transplantation and lung disease, and many pa-
tients have more than one underlying contributing condi-
tion.69,79,98 Approximately three quarters of cases are
unilateral and one quarter ultimately involve both eyes. More
than half have spread to other organs. Blurred vision, eye
pain and redness are common and in one study, vitritis was
observed in 45 of 73 cases and retinal lesions or chorioretini-
tis in another 28. Only 2 patients had anterior chamber
involvement.98 This distribution is consonant with vitrectomy
as the most reliable means of organism diagnosis.79,83
Recovery of useful vision has been reported in 0–10%.75,98
Just over half of the patients have a diagnosis of Aspergillus
endophthalmitis made only after autopsy98 and in cancer pa-
tients, filamentous fungal endophthalmitis such as Aspergil-
lus sp. is a marker for high mortality.69,79 Brain, lung and
heart (endocarditis) are other typical sites of involvement at
post-mortem.
Endogenous bacterial endophthalmitis is much less fre-
quent than endogenous fungal endophthalmitis or exoge-
nous bacterial endophthalmitis with an incidence of 2–
11%.80 Age ranged from neonates to patients greater than
90 years old with a mean of 50–60 years of age depending
on the population/literature assessed.80 Nineteen percent
were bilateral in one study.99 Patients often complain of
blurred vision with ocular pain and most but not all have evi-
dence of systemic illness. Examination reveals hypopyon and
hazy ocular media.80,99 Both Gram positive and Gram nega-
tive bacteria have been reported as pathogens with inci-
dences differing around the world. For example, several
reports of East Asian populations76,99–101 have clearly docu-
mented K. pneumoniae as the predominant endogenous
endophthalmitis cause, with hepatobiliary infections (espe-
cially liver abscesses), as the initial disease site and diabetes
mellitus a common co-existing condition.99 Elsewhere in the
world, S. aureus, Group B Streptococcus and S. pneumoniae
have been more frequent.68,80,81 In Caucasians, endocarditis,
skin/joint and urinary tract infections were common organism
sources.80,87,99,102 Other noteworthy pathogens include P.
aeruginosa which is more frequent in individuals younger
than 25 years of age including neonates80 and Neisseria men-
ingitidis which was noted to be decreasing in incidence in the
1980s but still a factor in childhood infections.103 Escherichia
coli has been isolated from endogenous endophthalmitis pa-
tients with urinary tract infections80 and from seemingly
healthy individuals who have endogenous bacterial endoph-
thalmitis.68 B. cereus has been associated with intravenous
drug use and, as in trauma-related cases, commonly pro-
gressed to evisceration/enucleation.80,103
As with endogenous fungal endophthalmitis, visual out-
comes are often poor regardless of the organism in-
volved.68,80,99,104 In Wong’s East Asian study, good visual
acuity returned in only 28% of cases.99 Similarly, Jackson in
his British cohort found 81% of affected eyes with light per-
ception or worse.80 More recent cases of K. pneumoniae
have had more patients with visual acuities of at least 10/
200, perhaps due to more clinical experience with the dis-
ease. However, overall results are still unsatisfactory withapproximately three-quarters of patients having a visual acu-
ity of 1.101 Statistical analysis has pointed to the virulence of
K. pneumoniae as the most important factor.99 This organism
has been isolated from multiple types of clinical specimens
and may colonize up to 20% of hospitalized patients.100 Ani-
mal models of K. pneumoniae endophthalmitis have shown
hypermucoviscosity phenotypes, K1 and K2 capsular pheno-
types and aerobactin production as virulence indicators. Re-
cently strains that produce beta-lactamase enzymes
conferring resistance to antibiotics frequently employed in
the treatment of Gram negative endophthalmitis have been
discovered.100 Experimentally, retinal destruction has ap-
peared as soon as 48 h post infection,100 so patients with
posterior infections and cloudy media at presentation are
more likely to do poorly.99 Timely diagnosis and treatment
are essential.Diagnosis
Aspirate of aqueous and/or vitreous for Gram stain is com-
monly employed for diagnosis; although helpful when posi-
tive for organisms, it is often not very sensitive. In the past,
culture has been the only available means of establishing
organism(s) causing endophthalmitis. As previously men-
tioned, in endogenous endophthalmitis, vitrectomy cultures
have proven the most reliable with poor concordance noted
between anterior chamber cultures and vitreous isolates.105
Recently, PCR has been found to be an important diagnostic
technique and has been reported to greatly aid in bacterial
and fungal detection.106,107 For example, in one real-time
PCR study, detection of bacteria improved from 47.6% to
95.3%.107 As with cultures, specimen contamination will yield
false positive results and poorly stored specimens can be so
degraded that they are not helpful. Another advantage of
PCR is its rapidity: results can be ready in as little as
90 min,87 a tremendous advantage over cultures, especially
for some slow-growing organisms such as mycobacteria. Fur-
ther, it can be performed on fixed paraffin embedded histol-
ogy specimens108,109 to identify organisms not diagnosed
presurgery/autopsy. PCR techniques are important diagnos-
tic tools that hopefully will become more widely available.Non-infectious endophthalmitis
This condition has diverse etiologies, and includes sys-
temic autoimmune diseases, local ocular inflammations of un-
known cause, endophthalmitis related to lens material and
endophthalmitis attributable to intraocular foreign bodies.
Phacoanaphylactic endophthalmitis (lens induced granu-
lomatous inflammation) is a rare consequence of lens injury
and represents an autoimmune response to lens protein to
which the body is normally tolerant.110 This may occur after
trauma, as a result of inflammation from other causes ruptur-
ing the lens capsule, or post surgery such as following extra-
capsular cataract extraction when residual lens cortex is
present. Histopathologically, a mixed neutrophilic and granu-
lomatous response is centered around the lens, typically in a
zonal pattern: neutrophils associated with degenerating lens
material are surrounded by giant cells and histiocytes which
are in turn encircled by chronic non-granulomatous inflamma-
tion. The condition is suspected clinically in only 5% of histo-
logically proven cases and thus is usually a surprise at
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fine needle aspiration biopsy.111 Seventy percent of cases
are associated with patchy choroidal non-granulomatous
inflammation, 60% with retinal detachment, 50% with retinal
mononuclear cell perivasculitis, 30% with optic atrophy and
3–7% with sympathetic ophthalmia.110,112
The term ‘‘phacotoxic’’ endophthalmitis was previously
used to cover a mixed group of conditions related to intraoc-
ular lens implant surgery. As the inflammation is centered ante-
riorly, the term toxic anterior segment syndrome (TASS) is
more appropriate. Causes include reactions to chemicals (irri-
gation solutions, preservatives, drugs, denatured viscoelas-
tics), IOL materials, instrument sterilization and preparation-
related compounds and bacterial endotoxins.113,114 The latter
are the result of bacterial growth killed by product sterilization
with the heat-resistant endotoxin remaining. In sufficient lev-
els, the endotoxin may produce sterile endophthalmitis.115
Sterile endophthalmitis has been noted as well following intra-
ocular injection, post vitrectomy and after surgery including
glaucoma drainage device implantation. Similar to TASS, the
condition may be multifactorial. Intravitreal triamcinolone ace-
tonide has been associated with pseudoendophthalmitis
caused by triamcinolone crystals migrating into the anterior
chamber; infectious and sterile endophthalmitis have also
been reported in association with this chemical.116
Clinically sterile endophthalmitis and TASS are differenti-
ated from infectious endophthalmitis by the former entities
typically arising within 24 h of surgery, being Gram stain
and culture negative, involving the anterior segment in the
case of TASS, and showing no effect from antibiotics but
improvement with topical and/or oral steroids. However, dis-
tinction may be problematic as some infectious cases may
have rapid onset and have initial negative cultures.113Conclusion
Through an improved understanding of the causes and
epidemiology of endophthalmitis will come further measures
for decreasing the incidence of this dreaded disease. Wide-
spread use of molecular techniques such as real-time PCR
promise to lessen diagnostic times and provide more accu-
rate diagnosis, permitting faster targeted therapies. On the
other hand, the rise of organisms such as methicillin resistant
S. aureus and other ‘‘super bugs’’ will necessitate constant
vigilance so that the successes achieved so far will not be lost.Acknowledgements
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